PRKCI and osteosarcoma: Abnormal expression of Prkci has been observed in various cancers, such as ovarian, hepatocellular carcinoma, pancreatic cancer, osteosarcoma, and lung cancer, where it often contributes to tumor progression and poor prognosis.